Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03124875 · ClinicalTrials.gov registry record · NA
PROMISE I Early Feasibility Trial of the LimFlow Stent Graft System
A NA study of Critical Limb Ischemia and Chronic Limb-Threatening Ischemia, sponsored by LimFlow.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 7
- Study locations
NCT03124875 is a NA study of Critical Limb Ischemia and Chronic Limb-Threatening Ischemia that has completed, run by LimFlow. The registered enrollment target is 32 participants, below the 90-participant average among 18 other Critical Limb Ischemia trials with a reported enrollment target (64% lower). The trial reports 7 study locations across 7 states.
The verdict
NCT03124875, a NA study of Critical Limb Ischemia and Chronic Limb-Threatening Ischemia, has completed, sponsored by LimFlow.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 7
- Study locations
Study Summary
This pilot study will investigate the safety, effectiveness and feasibility of the LimFlow Stent Graft System for creating an AV fistula in the Below The Knee (BTK) vascular system using an endovascular, minimally invasive approach for the treatment of Critical Limb Ischemia (CLI) in subjects ineligible for conventional endovascular or surgical limb salvage procedures.
Conditions Studied
Interventions
- DEVICE LimFlow System
Study Locations (7)
District of Columbia
- Medstar Washington Hospital Center - Washington D.C.
Hawaii
- Kaiser Permanente - Honolulu
Michigan
- Metro Health, University of Michigan - Wyoming
New Mexico
- New Mexico Heart Institute - Albuquerque
New York
- Mount Sinai Health System - New York
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
South Carolina
- Palmetto Health - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2017-07-05 |
| Est. Completion | 2021-01-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03124875
The ClinicalTrials.gov registry entry for NCT03124875 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90-participant average among 18 other Critical Limb Ischemia trials with a reported enrollment target (64% lower). The listed sponsor is LimFlow, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Critical Limb Ischemia appearing as the primary indexed condition, and to 1 intervention - of which LimFlow System is the first listed.
NCT03124875 reports 7 study locations spanning 7 distinct geographic areas - top geographies include District of Columbia, Hawaii, Michigan.
Frequently Asked Questions
What is clinical trial NCT03124875 about?
NCT03124875 is a clinical study titled "PROMISE I Early Feasibility Trial of the LimFlow Stent Graft System". This pilot study will investigate the safety, effectiveness and feasibility of the LimFlow Stent Graft System for creating an AV fistula in the Below The Knee (BTK) vascular system using an endovascular, minimally invasive approach for the treatment of Critical Limb Ischemia (CLI) in subjects inelig...
What is the current status of trial NCT03124875?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2017-07-05. Estimated completion is 2021-01-05.
What conditions does trial NCT03124875 study?
This clinical trial studies the following conditions: Critical Limb Ischemia, Chronic Limb-Threatening Ischemia.
What interventions are being tested in trial NCT03124875?
The interventions under investigation include: LimFlow System (DEVICE).
Who is sponsoring clinical trial NCT03124875?
This trial is sponsored by LimFlow, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03124875 being conducted?
This trial has 7 study locations across District of Columbia, Hawaii, Michigan, New Mexico, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Limb Ischemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MOTIV BTK Randomized Controlled Trial
RECRUITING · NA
-
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
RECRUITING · NA
-
Serrantor OCT Study
RECRUITING · NA
-
Lutonix DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries
COMPLETED · NA
-
A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL)
COMPLETED · NA
-
BOLD MRI as a Surrogate of Improved Muscle Oxygenation Following Endovascular Therapy for the Treatment of CLI
COMPLETED · NA
Explore more on PlainTrial
Critical Limb Ischemia
All registered trials for this condition
Chronic Limb-Threatening Ischemia
All registered trials for this condition
District of Columbia
All trials with a study site in District of Columbia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.